Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).

Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F; ANRS CO13 HEPAVIH Study Group.

Clin Infect Dis. 2015 Jul 1;61(1):40-8. doi: 10.1093/cid/civ217. Epub 2015 Mar 16.

PMID:
25778750
2.

Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.

Pedergnana V, Syx L, Cobat A, Guergnon J, Brice P, Fermé C, Carde P, Hermine O, Le-Pendeven C, Amiel C, Taoufik Y, Alcaïs A, Theodorou I, Besson C, Abel L.

PLoS One. 2014 Jul 15;9(7):e102501. doi: 10.1371/journal.pone.0102501. eCollection 2014.

3.

High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.

Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group.

Clin Infect Dis. 2014 Oct 15;59(8):1190-2. doi: 10.1093/cid/ciu525. Epub 2014 Jul 11. No abstract available.

PMID:
25015913
4.

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.

PMID:
23978720
5.

Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.

Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G.

Med Mal Infect. 2013 Jun;43(6):222-5. doi: 10.1016/j.medmal.2013.02.011. Epub 2013 Apr 15.

PMID:
23597924
6.

Detection and genotyping of human papillomavirus by real-time PCR assay.

Moreau F, Fetouchi R, Micalessi I, Brejeon V, Bacon N, Jannes G, Le Pendeven C, Lekbaby B, Kremsdorf D, Lacau Saint Guily J, Soussan P.

J Clin Virol. 2013 Mar;56(3):244-9. doi: 10.1016/j.jcv.2012.11.003. Epub 2012 Nov 22.

PMID:
23182775
7.

Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.

Loko MA, Bani-Sadr F, Valantin MA, Lascoux-Combe C, Fontaine H, Bonnard P, Gervais A, Bouchaud O, Garipuy D, Quertainmont Y, Vittecoq D, Tehrani MS, Winnock M, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group.

Antivir Ther. 2012;17(7):1335-43. doi: 10.3851/IMP2419. Epub 2012 Oct 10.

PMID:
23052829
8.

Production of hepatitis B defective particles is dependent on liver status.

Redelsperger F, Lekbaby B, Mandouri Y, Giang E, Duriez M, Desire N, Roque Afonso AM, Brichler S, Dubreuil P, Dobrin A, Perlemuter G, Prevot S, Bacon N, Grange JD, Zatla F, Le Pendeven C, Pol S, Strick-Marchand H, Di Santo J, Kremsdorf D, Soussan P.

Virology. 2012 Sep 15-30;431(1-2):21-8. doi: 10.1016/j.virol.2012.05.008. Epub 2012 Jun 2.

9.

Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.

Chakvetadze C, Bani-Sadr F, Le Pendeven C, Lescure FX, Fontaine C, Galperine T, Slama L, Bonnard P, Mariot P, Soussan P, Pialoux G.

Clin Infect Dis. 2010 Apr 15;50(8):1184-6. doi: 10.1086/651422.

PMID:
20210647
10.

Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

Bonnard P, Sombié R, Lescure FX, Bougouma A, Guiard-Schmid JB, Poynard T, Calès P, Housset C, Callard P, Le Pendeven C, Drabo J, Carrat F, Pialoux G.

Am J Trop Med Hyg. 2010 Mar;82(3):454-8. doi: 10.4269/ajtmh.2010.09-0088.

11.

Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.

Besson C, Amiel C, Le-Pendeven C, Plancoulaine S, Bonnardel C, Ranque B, Abbed K, Brice P, Fermé C, Carde P, Hermine O, Raphael M, Bresson JL, Nicolas JC, Gessain A, Dethe G, Abel L.

J Infect Dis. 2009 Apr 15;199(8):1121-7. doi: 10.1086/597424.

PMID:
19284285
12.

Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring.

Pol J, Le Pendeven C, Beby-Defaux A, Rabut E, Jais JP, Pilloux M, Osada C, Zatla F, Assami H, Grange JD, Kremsdorf D, Nicolas JC, Soussan P.

J Virol Methods. 2008 Dec;154(1-2):1-6. doi: 10.1016/j.jviromet.2008.09.014. Epub 2008 Nov 4.

PMID:
18929599
13.

Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease.

Soussan P, Pol J, Garreau F, Schneider V, Le Pendeven C, Nalpas B, Lacombe K, Bonnard P, Pol S, Kremsdorf D.

J Infect Dis. 2008 Jul 15;198(2):218-25. doi: 10.1086/589623.

PMID:
18532883
14.

Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.

Ghillani P, Rouquette AM, Desgruelles C, Hauguel N, Le Pendeven C, Piette JC, Musset L.

Ann N Y Acad Sci. 2007 Aug;1109:407-13.

PMID:
17785329
15.

Hepatitis B escape mutant reactivation in a renal transplant patient.

Le Pendeven C, Cuzon G, Fontaine H, Zatla F, Schneider V, Amiel C, Khayat R, Nicolas JC, Soussan P.

J Clin Virol. 2007 Sep;40(1):74-6. Epub 2007 Jul 24. No abstract available.

PMID:
17652016
16.

Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies.

Chakvetadze C, Bani-Sadr F, Le Pendeven C, Lamontagne F, Vincensini JP, Pialoux G.

AIDS. 2007 Jan 30;21(3):393-4. No abstract available.

PMID:
17255759
17.

Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.

Besson C, Amiel C, Le-Pendeven C, Brice P, Fermé C, Carde P, Hermine O, Raphael M, Abel L, Nicolas JC.

J Clin Microbiol. 2006 Jan;44(1):47-50.

18.

Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy.

Reijasse D, Le Pendeven C, Cosnes J, Dehee A, Gendre JP, Nicolas JC, Beaugerie L.

Inflamm Bowel Dis. 2004 Mar;10(2):85-90.

PMID:
15168806
19.

Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe dEtude Des Mycobactéries de la Seine-Saint-Denis.

Lortholary O, Deniel F, Boudon P, Le Pennec MP, Mathieu M, Soilleux M, Le Pendeven C, Loiseau P, Vincent V, Valeyre D.

Int J Tuberc Lung Dis. 1999 Jan;3(1):68-73.

PMID:
10094172
20.

Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area.

Gutiérrez MC, Vincent V, Aubert D, Bizet J, Gaillot O, Lebrun L, Le Pendeven C, Le Pennec MP, Mathieu D, Offredo C, Pangon B, Pierre-Audigier C.

J Clin Microbiol. 1998 Feb;36(2):486-92.

Supplemental Content

Loading ...
Support Center